ATLANTA--(BUSINESS WIRE)--The scientific staff at Saint Joseph’s Translational Research Institute (SJTRI) has announced that a new thin, bare metal stent (BMS) has been approved for sale by European Union regulators. Medlogics Device Corporations’ COBRA™ Coronary Stent System received the CE Mark based on the chronic preclinical implants performed at SJTRI which demonstrated the safety and efficacy of the stent.
